Pulmonary actinomycosis complicating infliximab therapy for Crohn's disease
| Autor: | R Enns, Russell D. Cohen, J Flint, J M Fitzgerald, W R Bowie |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
Lung Diseases
Male Pulmonary and Respiratory Medicine medicine.medical_specialty Tuberculosis Case Report Disease Opportunistic Infections Actinomycosis Gastroenterology Crohn Disease Gastrointestinal Agents Internal medicine Humans Medicine Crohn's disease Gastrointestinal agent business.industry Respiratory disease Antibodies Monoclonal Middle Aged medicine.disease Infliximab Immunology business Complication medicine.drug |
| Zdroj: | Thorax. 62:1013-1014 |
| ISSN: | 0040-6376 |
| DOI: | 10.1136/thx.2006.075150 |
| Popis: | The use of anti-tumour necrosis factor (TNF) agents has expanded significantly over the past few years, particularly for rheumatological diseases and Crohn's disease. A number of associated opportunistic infections have been observed as a result of suppression of T cell-mediated immunity, the most frequent being tuberculosis. We report the first case of pulmonary actinomycosis in a patient receiving regular infusions of infliximab, an anti-TNF agent, for Crohn's disease. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|